Dietary supplementation with S-adenosyl methionine was associated with protracted reduction of seizures in a line of transgenic mice

Comparative Medicine

Volumn 58, Issue 6, 2008, Pages 604-606

  Perry, Sheryl ^a   Levasseur, James ^a   Chan, Amy ^a   Shea, Thomas B ^a  

^a UNIVERSITY OF MASSACHUSETTS LOWELL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROTRANSMITTER; NUTRACEUTICAL; S ADENOSYLMETHIONINE;

AGGRESSION; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; MAZE TEST; MOUSE; NONHUMAN; REGULATORY MECHANISM; SEIZURE; SHORT COURSE THERAPY; TRANSGENIC MOUSE; TREATMENT WITHDRAWAL; WORKING MEMORY;

ALZHEIMER DISEASE; ANIMALS; APOLIPOPROTEIN E4; BEHAVIOR, ANIMAL; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; HUMANS; MAZE LEARNING; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; RECOMBINANT PROTEINS; S-ADENOSYLMETHIONINE; SEIZURES;

EID: 59049106791     PISSN: 15320820     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Balcombe JP, Barnard ND, Sandusky C. 2004. Laboratory routines cause animal stress. Contemp Top Lab Anim Sci 43:42-51.
2. Blümcke I, Brockhaus A, Scheiwe C, Rollbrocker B, Wolf HK, Elger CE, Wiestler OD. 1997. The apolipoprotein E e4 allele is not associated with early onset temporal lobe epilepsy. Neuroreport 8:1235-1237.
3. Briellmann RS, Torn-Broers Y, Busuttil BE, Major BJ, Kalnins RM, Olsen M, Jackson GD, Frauman AG, Berkovic SF. 2000. APOE ε4 genotype is associated with an earlier onset of chronic temporal lobe epilepsy. Neurology 55:435-437.
4. Busch RM, Lineweaver TT, Naugle Rl, Kim KH, Gong Y, Tilelli CQ, Prayson RA, Bingaman W, Najm IM, Diaz-Arrastia R. 2007. ApoE-ε4 is associated with reduced memory in long-standing intractable temporal lobe epilepsy. Neurology 68:409-414.
5. Chan A, Shea TB. 2008. S-adenosyl methionine: a natural therapeutic agent effective against multiple hallmarks and risk factors associated with Alzheimer disease. J Alzheimer Dis 13: 67-70
6. Chan A, Tchantchou F, Graves V, Rozen R, Shea TB. 2008. Dietary and genetic compromise in folate availability reduces acetylcholine and cognitive performance: critical role of S-adenosylmethionine. J Nutr Health Aging 12:252-261.
7. Conn D, Thorpe L. 2007. Assessment of behavioural and psychological symptoms associated with dementia. Can J Neurol Sci 34:S67-S71.
8. Curcio M, Catto E, Stramentinoli G, Algeri S. 1978. Effect of S-adenosyl-L-methionine on serotonin metabolism in rat brain. Prog Neuropsychopharmacol 2:65-71.
9. Farrar C, Clarke S. 2002. Altered levels of S-adenosylmethionine and S-adenosylhomocysteine in the brains of L-isoaspartyl (D-aspartyl) O-methyltransferase-deficient mice. J Biol Chem 277:27856-27863.
10. Farrar CE, Clarke S. 2005. Diet-dependent survival of protein repair-deficient mice. J Nutr Biochem 16:554-561.
11. Hoffman DR, Marion DW, Cornatzer WE, Duerre JA. 1980. S-Adenosylmethionine and S-adenosylhomocystein metabolism in isolated rat liver. Effects of L-methionine, L-homocystein, and adenosine. J Biol Chem 255:10822-10827.
12. Jegstrup I, Thon R, Hansen AK, Hoitinga MR. 2003. Characterization of transgenic mice: a comparison of protocols for welfare evaluation and phenotype characterization of mice with a suggestion on a future certificate of instruction. Lab Anim 37:1-9.
13. Kamboh MI. 1995. Apolipoprotein E polymorphism and susceptibility to Alzheimer disease. Hum Biol 67:195-215.
14. Lamango NS, Charlton CG. 2000. Farnesyl-L-cysteine analogs block SAM-induced Parkinson disease-like symptoms in rats. Pharmacol Biochem Behav 66:841-849.
15. Loehrer FM, Schwab R, Angst CP, Haefeli WE, Fowler B. 1997. Influence of oral S-adenosylmethionine on plasma 5-methyltetrahy-drofolate, S-adenosylhomocysteine, homocysteine, and methionine in healthy humans. J Pharmacol Exp Ther 282:845-850.
16. Mihalick SM, Ortiz D, Kumar R, Rogers E, Shea TB. 2003. Folate and vitamin E deficiency impair cognitive performance in mice subjected to oxidative stress: differential impact on normal mice and mice lacking apolipoprotein E. Neuromolecular Med 4:197-202.
17. Nelson ED, Kavalali ET, Monteggia LM. 2008. Activity-dependent suppression of miniature neurotransmission through the regulation of DNA methylation. J Neurosci 28:395-406.
18. Nguyen PV. 2006. Comparative plasticity of brain synapses in inbred mouse strains. J Exp Biol 209:2293-2303.
19. Otero-Losada ME, Rubio MC. 1989. Acute changes in 5-HT metabolism after S-adenosyl-L-methionine administration. Gen Pharmacol 20:403-406.
20. Picciotto MR, Wickman K. 1998. Using Knockout and Transgenic Mice to Study Neurophysiology and Behavior. Physiol Rev 78:1131-1163.
21. Schatz RA, Wilens TE, Sellinger OZ. 1981. Decreased transmethylation of biogenic amines after in vivo elevation of brain S-adenosyl-l-homocysteine. J Neurochem 36:1739-1748.
22. Sellinger OZ, Schatz RA, Porta R, Wilens TE. 1984. Brain methylation and epileptogenesis: the case of methionine sulfoximine. Ann Neurol 16:S115-S120.
23. Shea TB. 2007. Effects of dietary supplementation with N-acetyl cysteine, acetyl-L-carnitine and S-adenosyl methionine on cognitive performance and aggression in normal mice and mice expressing human ApoE4. Neuromolecular Med 9:264-269.
24. Stramentinoli G, Gualano M, Galli-Kienle M. 1979. Intestinal absorption of S-adenosyl-L-methionine. J Pharmacol Exp Ther 209:323-326.
25. Tchantchou F, Graves M, Ortiz D, Shea TB. 2006. S-adenosyl methionine: a link between nutritional and genetic risk factors in Alzheimer disease. J Nutr Health Aging 10:541-544.
26. Voigt JP, Rex A, Bader M, Fink H. 2000. From genotype to pheno-type-behavior of the transgenic rat TGR(mRen2)27 as an example. Rev Neurosci 11:37-45.
27. Zdanys KF, Kleiman TG, MacAvoy MG, Black BT, Rightmer TE, Grey M, Garman KS, Tampi RR, Gelernter J, van Dyck CH. 2007. Apolipoprotein E ε4 allele increases risk for psychotic symptoms in Alzheimer disease. Neuropsychopharmacology 32:171-179.